← All resources

July 14, 2026

What Is a CDA in Clinical Trials? CDA, NDA, and CTA Explained

A CDA is usually the first contract a trial site signs. What a CDA, NDA, and CTA are, when you sign each, and which one actually deserves a close read.

A CDA is the first piece of paper you'll usually sign when a sponsor wants to talk to you about a study. It stands for Confidentiality Disclosure Agreement, and it's the same idea as an NDA. There are a few agreements that show up as you become a site, so here's what each one is and which one actually matters.

CDA and NDA are the same thing

A CDA (Confidentiality Disclosure Agreement) and an NDA (Non-Disclosure Agreement) are, for all practical purposes, the same document wearing two different names. In clinical research you'll hear CDA more often. Either way, it's a promise: if the sponsor shares confidential information with you, you'll keep it confidential and only use it to evaluate the study.

Why you sign it first

Before a sponsor sends you a full protocol, they need to protect it. The protocol has proprietary details about the drug and the study design that they don't want floating around. So the CDA comes early, often before you've even seen enough to decide whether you want the study. Signing it doesn't commit you to running the trial. It only commits you to confidentiality. It unlocks the conversation, nothing more.

What a CDA covers

Most CDAs are short and cover the same ground:

  • What counts as confidential information
  • That you'll only use it to assess the study
  • How long the obligation lasts
  • What you do with the materials if you decide not to proceed

For a small site, the majority of CDAs are standard boilerplate. Read it anyway, and get legal help for anything that looks unusual or one-sided.

The CTA is the one that matters

Here's the thing to remember: the CDA is not the deal. The Clinical Trial Agreement, or CTA, is the real contract, and it comes later, after feasibility. The CTA covers the budget, payment terms, each side's obligations, indemnification, publication rights, and intellectual property. This is the document worth negotiating and worth having a lawyer review. The payment terms and holdbacks that shape your cash flow live here, which is covered in how much clinical trial sites get paid.

The rough order

  1. Sign the CDA (confidentiality)
  2. See the full protocol
  3. Go through feasibility
  4. Negotiate the CTA and budget
  5. Get IRB approval and start up

The full walkthrough is in how to become a clinical trial site.

What to watch for

  • Read the CDA even when it's routine. Occasionally the terms are broader than they should be.
  • Keep track of what you've signed and with whom. Once you're talking to several sponsors, this piles up fast.
  • Save your real scrutiny for the CTA. That's where the money and the risk are.

Want to see which sponsors are worth starting that conversation with? Start a free TrialWave trial, no card required.


This is general information, not legal advice. Have qualified counsel review any agreement before you sign it.

Put this into practice at your site

TrialWave helps small research sites find better-fit studies, run sponsor and CRO outreach, and look sponsor-ready — without hiring a business-development manager.

14-day free trial — no card required.